DAVID JORDEN - 01 Aug 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role: CEO/CFO, Director
Signature: /s/ David Jorden
Issuer symbol: AURX
Transactions as of: 01 Aug 2025
Transactions value $: $39,999
Form type: 4
Filing time: 04 Aug 2025, 09:09:44 UTC
Previous filing: 14 Nov 2022
Next filing: 03 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
JORDEN DAVID EMERSON	CEO/CFO, Director	C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON	/s/ David Jorden	04 Aug 2025	0001313516

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AURX	Common Stock	Options Exercise	$40K	+100K	+5.06%	$0.40	2.08M	01 Aug 2025	Direct
transaction	AURX	Common Stock	Options Exercise	$37.1K	+92.7K	+4.47%	$0.40	2.17M	01 Aug 2025	Direct
transaction	AURX	Common Stock	Tax liability	-$37.1K	-21.3K	-0.98%	$1.74	2.15M	01 Aug 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AURX	Option to purchase common stock	Options Exercise	$0	-193K	-100%	$0.00	0	09 Aug 2018	Common Stock	193K	$0.40	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a net exercise of outstanding stock options. The reporting person received 71,397 shares of common stock on the net exercise of option to purchase 92,710 shares of common stock. The issuer withheld 21,313 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74.